These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 1907714

  • 21. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J, Legakis NJ, Nicolas KJ, Melissinos K, Papavassiliou J.
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [Abstract] [Full Text] [Related]

  • 22. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO, Izard D, Leclerc H.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [Abstract] [Full Text] [Related]

  • 23. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE, Coude du Foresto B, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [Abstract] [Full Text] [Related]

  • 24. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ, Robson HG.
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [Abstract] [Full Text] [Related]

  • 25. [Profiles of resistance to aminosides of Pseudomonas aeruginosa].
    Lesage D, Delisle-Mizon F, Vergez P, Daguet G.
    Pathol Biol (Paris); 1987 May; 35(5):552-7. PubMed ID: 3112707
    [Abstract] [Full Text] [Related]

  • 26. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
    Vincent P, Vachée A, Izard D.
    Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
    [Abstract] [Full Text] [Related]

  • 27. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H.
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [Abstract] [Full Text] [Related]

  • 28. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C, Crevatin E.
    Ann Sclavo; 1977 Nov; 19(3):437-45. PubMed ID: 415672
    [Abstract] [Full Text] [Related]

  • 29. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
    Barry AL, Miller GH, Thornsberry C, Hare RS, Jones RN, Lorber RR, Ferraresi R, Cramer C.
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
    [Abstract] [Full Text] [Related]

  • 30. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS.
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [Abstract] [Full Text] [Related]

  • 31. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C, Kauffman CA.
    Infection; 1978 Dec; 6(3):111-5. PubMed ID: 98451
    [Abstract] [Full Text] [Related]

  • 32. Survey of aminoglycoside resistance patterns.
    Legakis NJ, Velonaki A, Velonakis EM, Lymberopoulou T.
    Chemioterapia; 1986 Jun; 5(3):185-90. PubMed ID: 3087636
    [Abstract] [Full Text] [Related]

  • 33. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW, Boelaert J, Glibert B, Gordts B, Verbruggen AM.
    Am J Med; 1986 Jun 30; 80(6B):76-81. PubMed ID: 3089007
    [Abstract] [Full Text] [Related]

  • 34. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H, Krcméry V, Mitsuhashi S.
    Zentralbl Bakteriol A; 1980 Mar 30; 246(3):373-8. PubMed ID: 6775445
    [Abstract] [Full Text] [Related]

  • 35. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH, Witt U.
    Arzneimittelforschung; 1979 Mar 30; 29(2):174-8. PubMed ID: 582126
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
    Hindler JA, Bruckner DA.
    J Clin Microbiol; 1987 Mar 30; 25(3):546-50. PubMed ID: 3571458
    [Abstract] [Full Text] [Related]

  • 37. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C, Barry AL, Jones RN, Baker CN, Badal RE, Packer RR.
    Antimicrob Agents Chemother; 1980 Aug 30; 18(2):338-45. PubMed ID: 7447410
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS, Singh NN.
    J Microbiol Immunol Infect; 2007 Feb 30; 40(1):45-9. PubMed ID: 17332906
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY, Wang FD, Ho MW, Lee CH, Liu JW, Wang JT, Sheng WH, Hseuh PR, Chang SC.
    J Microbiol Immunol Infect; 2016 Dec 30; 49(6):918-923. PubMed ID: 26364729
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.